Benchmark Holdings PLC Notice of Q1 Results (5234A)

TIDMBMK

RNS Number : 5234A

Benchmark Holdings PLC

23 January 2024

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

Notice of Q1 Results

Webcast for analysts and institutional investors

Equity Development webcast for retail investors

Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture biotechnology business, will announce its Q1 results, for the three month period ended 31 December 2023, on Thursday 15 February 2024.

Presentation for analysts and institutional investors at 9.30am GMT

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a presentation for analysts and institutional investors on the day at 09.30 GMT (10.30 CET).

The presentation will be held in person at Haakon Vlls Gate 2, Oslo, Norway. To register your interest, please contact benchmark@mhpgroup.com

A live webcast of the presentation will be available for analysts and investors to join remotely at the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20240215_10

Equity Development webcast for retail investors at 12:00pm UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a second webcast for retail investors and wealth managers at 12.00pm UK time. The webcast is open to all existing and potential shareholders.

To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1-investor-presentation-15february2024

Enquiries

 
 For further information, please contact: 
  Benchmark Holdings plc                     Tel: 0114 240 9939 
  Trond Williksen, CEO 
  Septima Maguire, CFO 
  Ivonne Cantu, Investor Relations 
 
 
  Deutsche Numis (Broker and NOMAD)          Tel: 020 7260 1000 
  Freddie Barnfield, Duncan Monteith, Sher 
   Shah 
 
  MHP                                        Tel: 020 3128 8100 
  Katie Hunt, Reg Hoare                      benchmark@mhpgroup.com 
 
   Equity Development                         Tel: 020 7065 2692 
   Hannah Crowe

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOREAXFAASKLEFA

(END) Dow Jones Newswires

January 23, 2024 02:00 ET (07:00 GMT)

Benchmark (LSE:BMK)
Historical Stock Chart
From Oct 2024 to Nov 2024